⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of SiteRx and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
SiteRx
↗New York, USA
SiteRx is a healthcare technology company that provides a clinical intelligence platform designed to streamline patient identification, matching, and enrollment in clinical trials. By integrating with electronic health records (EHR) and using AI-driven technology, the company helps healthcare providers and research sites identify eligible patients for clinical research, with a strong focus on neurodegenerative diseases like Alzheimer's, Parkinson's, and Multiple Sclerosis.
The company operates as a HIPAA-compliant business associate, acting as an extension of medical practices to improve transparency and diversity in clinical research. Their mission is to democratize access to clinical trials by removing barriers for patients, physicians, and sponsors, ultimately aiming to accelerate the development of new therapies.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Clinical Trial Recruitment / Healthcare IT
SIZE & FINANCIALS
Employees:51-200
Founded:2019
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$6.07M
Investors:First Round Capital, Columbia Business School Lang Fund
0
CORPORATE STRUCTURE
Key Partnerships:Various neurology clinics and research centers across the United States
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Seth Goodman - CEO
Manoj Pooleery - Co-Founder & CTO
Michael Stalder - COO
Scientific Founders:Seth Goodman
LINKS
Website:siterx.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SiteRx. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.